1 report

  • 01/03/2017: Cryoport Supports Gradalis' Vigil Platform in Clinical Trials for Autologous Immunotherapies for Multiple Cancers

Summary Gradalis Inc (Gradalis), formerly Murex Pharmaceuticals, is a biopharmaceutical company which focuses on the development and commercialization of therapies for the treatment of cancer.Its developmental pipeline comprises of candidates for various cancer indications which include ovarian, breast, melanoma, Ewing’s...

  • Cancer
  • Healthcare
  • Pathology
  • United States
  • Gradalis, Inc.